Polyfunctional Cytokines
Title | Polyfunctional Cytokines PDF eBook |
Author | Gregory R. Bock |
Publisher | John Wiley & Sons |
Total Pages | 290 |
Release | 2008-04-30 |
Genre | Science |
ISBN | 0470514272 |
Experts from a variety of areas compare and discuss IL-6 and LIF in order to provide a new understanding of their modes of action, the significance of their polyfunctionalization--why the body chooses to use one molecule to regulate various cell types--and their functional overlap. Covers such topics as actions of IL-6 and LIF on lymphoid populations, on megakaryocyte and platelet production, on bone metabolism, their effects on leukemic cells and much more. Includes contributions from researchers working on a variety of cell types and organ systems along with potential clinical applications regarding these two factors.
Reassessing Twenty Years of Vaccine Development Against Tuberculosis
Title | Reassessing Twenty Years of Vaccine Development Against Tuberculosis PDF eBook |
Author | Ulrich E. Schaible |
Publisher | Frontiers Media SA |
Total Pages | 110 |
Release | 2018-03-23 |
Genre | |
ISBN | 2889454460 |
Tuberculosis (TB) remains the prime bacterial infection worldwide with 10.4 million infections and a death toll of 1.7 million people in 2016 according to WHO statistics. Tuberculosis is caused by members of the Mycobacterium tuberculosis complex, facultative intracellular bacteria able to thrive within otherwise potent innate defense cells, the macrophages. In a world of increasing numbers of infections with drug resistant M. tuberculosis strains, the daunting race between developing new therapeutics and emerging resistant strains will hardly produce a winner. This cycle can only be broken by enhancing population wide immune control through a better vaccine as the only one currently in use, M. bovis Bacillus Calmette Guerin (BCG). The protective efficacy of BCG against pulmonary tuberculosis in all age groups is dissatisfying and geographically highly diverse with the tropical areas showing the lowest efficacy rates. Despite worldwide vaccination coverage, the impact of BCG on the steep decrease of tuberculosis incidence rates in the developed world seems therefore questionable and can rather be attributed to improved social, housing and nutritional conditions, better health care, surveillance and treatment systems. The last 15 years saw tremendous efforts to improve vaccination strategies against tuberculosis. Different paths of vaccine approaches were followed including genetically improved BCG strains, attenuated M. tuberculosis variants, recombinant viral vectors and subunit vaccine candidates combined with novel more potent adjuvants. With the first novel vaccine candidates being evaluated in clinical phases II and III and initial results chastening the expectations, a critical reassessment of all candidates is inevitable. Here, we assembled experts to review and assess the current status of novel anti-tuberculosis vaccine candidates, their efficacy and prospects for implementation as well as the pitfalls and possible measures for improvement.
Developments in T Cell Based Cancer Immunotherapies
Title | Developments in T Cell Based Cancer Immunotherapies PDF eBook |
Author | Paolo A. Ascierto |
Publisher | Humana Press |
Total Pages | 305 |
Release | 2015-11-26 |
Genre | Medical |
ISBN | 3319211676 |
This volume illustrates the salient aspects of cancer biology relevant to the successful implementation of immunotherapy. Topics include enhancement of antigen-specific immune responses by anti-cancer vaccines, modulation of the function of T cells within the tumor microenvironment, and the effects of genetic, epigenetic, developmental, and environmental determinants on T cell function. Other topics covered include the ex vivo expansion of T or other immune cells and their genetic modification or reprogramming to increase their ability to survive and expand when adoptively transferred back to the patients. Specific attention is devoted to the genetic manipulation of T cells through the introduction of re-directed T cell receptors, chimeric antibody receptors, and other genetic manipulation aimed at improving their effectiveness as anti-cancer agents. Furthermore, the revolutionary role of checkpoint inhibitors and their potential in combination with other immunotherapeutic approaches or with standard chemo and radiation therapy are extensively discussed.
Exploring Immune Variability in Susceptibility to Tuberculosis Infection in Humans
Title | Exploring Immune Variability in Susceptibility to Tuberculosis Infection in Humans PDF eBook |
Author | Julie G. Burel |
Publisher | Frontiers Media SA |
Total Pages | 169 |
Release | 2022-02-16 |
Genre | Medical |
ISBN | 2889744051 |
Handbook of ELISPOT
Title | Handbook of ELISPOT PDF eBook |
Author | Alexander E. Kalyuzhny |
Publisher | Springer Nature |
Total Pages | 321 |
Release | |
Genre | |
ISBN | 1071636901 |
Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges
Title | Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges PDF eBook |
Author | Myron Christodoulides |
Publisher | Springer Nature |
Total Pages | 337 |
Release | 2023-03-27 |
Genre | Medical |
ISBN | 3031243552 |
This book reviews successes and (remaining) challenges in vaccine development for the selected Neglected Tropical Diseases (NTD) of Leprosy, Leishmaniasis, Meliodoisis and Tuberculosis, which are a continuous burden for millions of people in affected areas worldwide. Written by frontline researchers, the volume deep-dives into different vaccine strategies, provides biotechnological background information and also tackles animal models in NTD therapeutics research. By bringing together state-of-the-art expert knowledge, the book contributes to the aim of ultimately ending the epidemics of neglected tropical diseases, complying with UN Sustainable Development Goal 3, Health and Well-Being. The volume highlights the activities of the research network VALIDATE (VAccine deveLopment for complex Intracellular neglecteD pAThogEns), funded by the Medical Research Council in the UK. The four NTDs discussed in the book were selected as these are in the focus of VALIDATE’s research. The book targets scientists and clinicians working on NTDs, as well as all readers with a background in biomedicine and interest in vaccine development. This is an open access book.
Immunotherapy in Translational Cancer Research
Title | Immunotherapy in Translational Cancer Research PDF eBook |
Author | Laurence J. N. Cooper |
Publisher | John Wiley & Sons |
Total Pages | 312 |
Release | 2018-02-12 |
Genre | Medical |
ISBN | 1118684524 |
A guide to state-of-the-art cancer immunotherapy in translational cancer research A volume in the Translational Oncology series, Immunotherapy in Translational Cancer Research explores the recent developments in the role that immunotherapy plays in the treatment of a wide range of cancers. The editors present key concepts, illustrative examples, and suggest alternative strategies in order to achieve individualized targeted therapy. Comprehensive in scope, Immunotherapy in Translational Cancer Research reviews the relevant history, current state, and the future of burgeoning cancer-fighting therapies. The book also includes critical information on drug development, clinical trials, and governmental resources and regulatory issues. Each chapter is created to feature: development of the immunotherapy; challenges that have been overcome in order to scale up and undertake clinical trials; and clinical experience and application of research. This authoritative volume is edited by a team of noted experts from MD Anderson Cancer Center, the world’s foremost cancer research and care center and: Offers a comprehensive presentation of state-of-the-art cancer immunotherapy research that accelerates the pace of clinical cancer care Filled with the concepts, examples, and approaches for developing individualized therapy Explores the breath of treatments that reflect the complexity of the immune system itself Includes contributions from a panel international experts in the field of immunotherapy Designed for physicians, medical students, scientists, pharmaceutical executives, public health and public policy government leaders and community oncologists, this essential resource offers a guide to the bidirectional interaction between laboratory and clinic immunotherapy cancer research.